cgp 39551 has been researched along with valine in 2 studies
| Studies (cgp 39551) | Trials (cgp 39551) | Recent Studies (post-2010) (cgp 39551) | Studies (valine) | Trials (valine) | Recent Studies (post-2010) (valine) |
|---|---|---|---|---|---|
| 75 | 0 | 4 | 15,465 | 1,176 | 3,932 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baud, J; Baumann, P; Bittiger, H; Fagg, GE; Olpe, HR; Portet, C; Pozza, MF; Schmutz, M; Steinmann, M; Thedinga, K | 1 |
| Brugger, F; Fagg, GE; Olpe, HR; Pozza, MF | 1 |
2 other study(ies) available for cgp 39551 and valine
| Article | Year |
|---|---|
CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Binding, Competitive; Electrophysiology; Electroshock; Glutamates; Hippocampus; In Vitro Techniques; Kinetics; Male; Neurotransmitter Agents; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Sodium; Valine | 1990 |
Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Electrophysiology; Hippocampus; Iontophoresis; Male; Oxadiazoles; Piperazines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord; Substantia Nigra; Valine | 1990 |